×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Aerovate Therapeutics Inc. (AVTE) NASDAQ

$13.42 0.08 (0.60%)

Market Cap: $368.85M

As of 10/04/23 04:00 PM EDT. Market closed.

(AVTE)

Aerovate Therapeutics Inc. (AVTE)
NASDAQ

$13.42
0.08 (0.60%)

Market Cap: $368.85M

As of 10/04/23 04:00 PM EDT. Market closed.

aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. aerovate's initial focus is on advancing av-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or ... read more

aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. aerovate's initial focus is on advancing av-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or pah. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
5
Address
.
PRICE CHART FOR AEROVATE THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$13.36
Previous Close
$13.34
Days Range
$13.05 - $13.69
52 week range
$12.29 - $30.79
Volume
36,665
Avg. Volume (30 days)
77,523
Market Cap
$368.85M
Dividend Yield
-
P/E
-
Shares Outstanding
27,650,000
Open
$13.36
Previous Close
$13.34
Days Range
$13.05 - $13.69
52 week range
$12.29 - $30.79
Volume
36,665
Avg. Volume (30 days)
77,523
Market Cap
$368.85M
Dividend Yield
-
P/E
-
Shares Outstanding
27,650,000
FINANCIAL STATEMENTS FOR AEROVATE THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AEROVATE THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Dake Benjamin TSEE REMARKSSep 07, 2023 Option Exercise$2.1430641,321Sep 08, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSSep 06, 2023 Option Exercise$1.893,9317,4475,222Sep 08, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSSep 07, 2023 Sale$15.01304501,291Sep 08, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSSep 06, 2023 Sale$15.063,93159,1871,291Sep 08, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSAug 07, 2023 Option Exercise$2.0510,28321,04111,574Aug 09, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSAug 07, 2023 Sale$15.5210,283159,5801,832Aug 09, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERJul 28, 2023 Option Exercise$2.145,47811,7235,478Aug 01, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERJul 28, 2023 Sale$18.005,47898,6040Aug 01, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERJul 17, 2023 Option Exercise$2.144,5229,6774,522Jul 19, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERJul 17, 2023 Sale$18.114,52281,8960Jul 19, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSJul 06, 2023 Option Exercise$2.0510,28321,04111,574Jul 07, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSJul 06, 2023 Sale$16.6610,283171,2841,291Jul 07, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERJul 05, 2023 Option Exercise$2.022,2504,5553,859Jul 07, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERJul 05, 2023 Sale$17.302,25038,9151,828Jul 07, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERJul 03, 2023 Option Exercise$2.1410,00021,40010,000Jul 05, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERJul 03, 2023 Sale$18.0010,000180,0000Jul 05, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSJun 06, 2023 Option Exercise$2.0510,28321,04111,574Jun 08, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSJun 06, 2023 Sale$16.2810,283167,4161,306Jun 08, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERJun 05, 2023 Option Exercise$2.022,2504,5553,859Jun 07, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERJun 05, 2023 Sale$16.262,25036,5761,609Jun 07, 2023, 06:00 PM
Gillies HunterCHIEF MEDICAL OFFICERMay 19, 2023 Option Exercise$1.74651133,316May 23, 2023, 06:00 PM
Gillies HunterCHIEF MEDICAL OFFICERMay 19, 2023 Sale$19.50651,2683,251May 23, 2023, 06:00 PM
Gillies HunterCHIEF MEDICAL OFFICERMay 17, 2023 Option Exercise$1.741,0901,8974,341May 19, 2023, 06:00 PM
Gillies HunterCHIEF MEDICAL OFFICERMay 17, 2023 Sale$19.591,09021,3563,251May 19, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERMay 05, 2023 Option Exercise$2.022,2504,5553,859May 09, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERMay 05, 2023 Sale$20.872,25046,9571,814May 09, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSMay 08, 2023 Option Exercise$2.0510,28421,04311,575May 09, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSMay 08, 2023 Sale$21.8010,284224,1602,890May 09, 2023, 06:00 PM
Verwijs MarinusSENIOR VICE PRESIDENT, CMCMay 03, 2023 Sale$20.7975915,7790May 05, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERMay 01, 2023 Option Exercise$2.1415,00032,10015,693May 03, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERMay 01, 2023 Sale$20.6115,000309,088693May 03, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERMay 02, 2023 Sale$21.1569314,6570May 03, 2023, 06:00 PM
Gillies HunterCHIEF MEDICAL OFFICERApr 21, 2023 Option Exercise$1.744,0006,9605,960Apr 25, 2023, 06:00 PM
Gillies HunterCHIEF MEDICAL OFFICERApr 21, 2023 Sale$19.504,00078,0001,960Apr 25, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSApr 06, 2023 Option Exercise$2.0510,28321,04110,283Apr 07, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSApr 06, 2023 Sale$18.1710,283186,8290Apr 07, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERApr 05, 2023 Option Exercise$2.022,2504,5553,859Apr 07, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERApr 05, 2023 Sale$18.202,25040,9422,144Apr 07, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERApr 03, 2023 Option Exercise$2.1415,00032,10015,000Apr 05, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERApr 03, 2023 Sale$19.3915,000290,9165,828Apr 05, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSMar 06, 2023 Option Exercise$2.0510,28221,03910,282Mar 08, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSMar 06, 2023 Sale$23.7310,282243,954215Mar 08, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERMar 06, 2023 Option Exercise$2.022,2504,5553,859Mar 08, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERMar 06, 2023 Sale$23.752,25053,4401,654Mar 08, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERMar 01, 2023 Option Exercise$2.1415,00032,10015,000Mar 03, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERMar 01, 2023 Sale$23.8115,000357,1969,038Mar 03, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSFeb 06, 2023 Option Exercise$2.0510,28421,04310,284Feb 08, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSFeb 06, 2023 Sale$24.5910,284252,8811,426Feb 08, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERFeb 06, 2023 Option Exercise$2.022,2504,5553,859Feb 08, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERFeb 06, 2023 Sale$24.272,25054,6121,609Feb 08, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERFeb 01, 2023 Option Exercise$2.1415,00032,10015,000Feb 03, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERFeb 01, 2023 Sale$22.6815,000340,1974,495Feb 03, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSJan 06, 2023 Option Exercise$2.0510,28421,04310,284Jan 09, 2023, 06:00 PM
Dake Benjamin TSEE REMARKSJan 06, 2023 Sale$25.9810,284267,2032,792Jan 09, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERJan 05, 2023 Option Exercise$2.022,2504,5553,859Jan 09, 2023, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERJan 05, 2023 Sale$26.402,25059,4051,609Jan 09, 2023, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERJan 03, 2023 Option Exercise$2.1415,00032,10015,000Jan 05, 2023, 05:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERJan 03, 2023 Sale$27.0715,000406,0763,073Jan 05, 2023, 05:00 PM
Dake Benjamin TSEE REMARKSDec 12, 2022 Option Exercise$2.142,0594,4062,059Dec 14, 2022, 06:00 PM
Dake Benjamin TSEE REMARKSDec 12, 2022 Sale$29.432,05960,5912,039Dec 14, 2022, 06:00 PM
Eldridge George ASEE REMARKSDec 09, 2022 Option Exercise$2.143,9698,4945,929Dec 13, 2022, 06:00 PM
Eldridge George ASEE REMARKSDec 12, 2022 Option Exercise$2.1410,00021,40011,960Dec 13, 2022, 06:00 PM
Eldridge George ASEE REMARKSDec 09, 2022 Sale$24.383,96996,7652,543Dec 13, 2022, 06:00 PM
Eldridge George ASEE REMARKSDec 12, 2022 Sale$30.0410,000300,4281,960Dec 13, 2022, 06:00 PM
Dake Benjamin TSEE REMARKSDec 09, 2022 Option Exercise$2.14394843394Dec 12, 2022, 06:00 PM
Dake Benjamin TSEE REMARKSDec 08, 2022 Option Exercise$2.1410,00021,40010,000Dec 12, 2022, 06:00 PM
Dake Benjamin TSEE REMARKSDec 09, 2022 Sale$25.033949,8610Dec 12, 2022, 06:00 PM
Dake Benjamin TSEE REMARKSDec 08, 2022 Sale$22.6410,000226,4499,072Dec 12, 2022, 06:00 PM
Eldridge George ASEE REMARKSDec 08, 2022 Option Exercise$2.1412,01125,70413,971Dec 09, 2022, 06:00 PM
Eldridge George ASEE REMARKSDec 07, 2022 Option Exercise$2.1411,63724,90313,597Dec 09, 2022, 06:00 PM
Eldridge George ASEE REMARKSDec 08, 2022 Sale$23.8712,011286,70013,011Dec 09, 2022, 06:00 PM
Eldridge George ASEE REMARKSDec 07, 2022 Sale$19.7711,637230,0836,518Dec 09, 2022, 06:00 PM
Dake Benjamin TSEE REMARKSDec 06, 2022 Option Exercise$2.1240,00084,63540,000Dec 08, 2022, 06:00 PM
Dake Benjamin TSEE REMARKSDec 06, 2022 Sale$17.6740,000706,77237,989Dec 08, 2022, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERDec 05, 2022 Option Exercise$2.022,2504,5553,859Dec 07, 2022, 06:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERDec 05, 2022 Sale$17.382,25039,1141,609Dec 07, 2022, 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERDec 01, 2022 Option Exercise$2.1415,00032,10015,000Dec 02, 2022, 07:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERDec 01, 2022 Sale$18.0015,000270,0000Dec 02, 2022, 07:00 PM
Eldridge George ASEE REMARKSNov 30, 2022 Option Exercise$2.14851822,045Dec 02, 2022, 07:00 PM
Eldridge George ASEE REMARKSNov 30, 2022 Sale$19.06851,6201,960Dec 02, 2022, 07:00 PM
Eldridge George ASEE REMARKSNov 23, 2022 Option Exercise$2.141,2612,6993,221Nov 28, 2022, 05:00 PM
Eldridge George ASEE REMARKSNov 23, 2022 Sale$19.071,26124,0481,960Nov 28, 2022, 05:00 PM
Eldridge George ASEE REMARKSNov 22, 2022 Option Exercise$2.141743722,134Nov 22, 2022, 08:00 PM
Eldridge George ASEE REMARKSNov 21, 2022 Option Exercise$2.14241,962Nov 22, 2022, 08:00 PM
Eldridge George ASEE REMARKSNov 18, 2022 Option Exercise$2.148611,8432,821Nov 22, 2022, 08:00 PM
Eldridge George ASEE REMARKSNov 22, 2022 Sale$19.011743,3081,960Nov 22, 2022, 08:00 PM
Eldridge George ASEE REMARKSNov 21, 2022 Sale$19.002381,960Nov 22, 2022, 08:00 PM
Eldridge George ASEE REMARKSNov 18, 2022 Sale$19.5286116,8052,041Nov 22, 2022, 08:00 PM
Dake Benjamin TSEE REMARKSNov 11, 2022 Option Exercise$2.146,19813,2646,198Nov 14, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSNov 10, 2022 Option Exercise$2.141,8003,8521,800Nov 14, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSNov 09, 2022 Option Exercise$2.1414,00029,96014,000Nov 14, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSNov 11, 2022 Sale$20.696,198128,2361,746Nov 14, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSNov 10, 2022 Sale$20.101,80036,1720Nov 14, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSNov 09, 2022 Sale$17.9114,000250,6770Nov 14, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSNov 08, 2022 Option Exercise$2.148,37317,9188,373Nov 09, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSNov 07, 2022 Option Exercise$2.0917,62736,75717,627Nov 09, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSNov 08, 2022 Sale$18.098,373151,4580Nov 09, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSNov 07, 2022 Sale$18.3217,627322,8946,505Nov 09, 2022, 05:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERNov 07, 2022 Option Exercise$2.022,2504,5553,859Nov 09, 2022, 05:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICERNov 07, 2022 Sale$19.202,25043,1943,409Nov 09, 2022, 05:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERNov 01, 2022 Sale$19.501,03820,2410Nov 03, 2022, 05:00 PM
Verwijs MarinusSENIOR VICE PRESIDENT, CMCNov 02, 2022 Sale$18.891,13021,3460Nov 03, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSOct 18, 2022 Option Exercise$2.145,70512,2095,705Oct 20, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSOct 18, 2022 Sale$21.085,705120,2870Oct 20, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSOct 14, 2022 Option Exercise$2.14110235110Oct 18, 2022, 05:01 PM
Dake Benjamin TSEE REMARKSOct 17, 2022 Option Exercise$2.144,1858,9564,185Oct 18, 2022, 05:01 PM
Dake Benjamin TSEE REMARKSOct 17, 2022 Sale$20.164,18584,3800Oct 18, 2022, 05:01 PM
Dake Benjamin TSEE REMARKSOct 14, 2022 Sale$20.051102,2050Oct 18, 2022, 05:01 PM
Dake Benjamin TSEE REMARKSOct 10, 2022 Option Exercise$2.144,95410,6024,954Oct 12, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSOct 10, 2022 Sale$16.894,95483,6811,430Oct 12, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSOct 06, 2022 Option Exercise$2.0713,04026,94113,040Oct 11, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSOct 07, 2022 Option Exercise$2.1410,52022,51310,520Oct 11, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSOct 07, 2022 Sale$16.0110,520168,4601,757Oct 11, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSOct 06, 2022 Sale$15.8213,040206,3441,830Oct 11, 2022, 05:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICEROct 05, 2022 Option Exercise$2.022,2504,5553,859Oct 07, 2022, 05:00 PM
NIVEN RALPHCHIEF SCIENTIFIC OFFICEROct 05, 2022 Sale$15.752,25035,4471,800Oct 07, 2022, 05:00 PM
Dake Benjamin TSEE REMARKSSep 12, 2022 Option Exercise$2.147,52016,0937,520Sep 14, 2022, 05:15 PM
Dake Benjamin TSEE REMARKSSep 12, 2022 Sale$17.337,520130,3072,248Sep 14, 2022, 05:15 PM
Dake Benjamin TSee RemarksSep 08, 2022 Option Exercise$1.743,1205,4293,120Sep 12, 2022, 05:30 PM
Dake Benjamin TSee RemarksSep 09, 2022 Option Exercise$2.124,7209,9984,720Sep 12, 2022, 05:30 PM
Dake Benjamin TSee RemarksSep 08, 2022 Sale$18.203,12056,782629Sep 12, 2022, 05:30 PM
Dake Benjamin TSee RemarksSep 09, 2022 Sale$17.544,72082,803176Sep 12, 2022, 05:30 PM
Dake Benjamin TSee RemarksSep 07, 2022 Option Exercise$1.748,22014,3038,220Sep 08, 2022, 05:30 PM
Dake Benjamin TSee RemarksSep 06, 2022 Option Exercise$1.749,16615,9499,166Sep 08, 2022, 05:30 PM
Dake Benjamin TSee RemarksSep 07, 2022 Sale$18.423,66367,4773,658Sep 08, 2022, 05:30 PM
Dake Benjamin TSee RemarksSep 06, 2022 Sale$18.539,166169,8764,744Sep 08, 2022, 05:30 PM
NIVEN RALPHChief Scientific OfficerSep 06, 2022 Option Exercise$2.022,2504,5553,859Sep 07, 2022, 05:30 PM
NIVEN RALPHChief Scientific OfficerSep 06, 2022 Sale$19.002,25042,7501,609Sep 07, 2022, 05:30 PM
NIVEN RALPHChief Scientific OfficerAug 18, 2022 Option Exercise$2.022,2504,5553,859Aug 19, 2022, 05:00 PM
NIVEN RALPHChief Scientific OfficerAug 18, 2022 Sale$21.182,25047,6571,609Aug 19, 2022, 05:00 PM
Dake Benjamin TSee RemarksAug 16, 2022 Option Exercise$1.7421,00036,54021,000Aug 18, 2022, 05:00 PM
Dake Benjamin TSee RemarksAug 16, 2022 Sale$23.0021,000482,93210,525Aug 18, 2022, 05:00 PM
Dake Benjamin TSee RemarksAug 11, 2022 Option Exercise$1.741,3472,3441,347Aug 12, 2022, 05:15 PM
Dake Benjamin TSee RemarksAug 10, 2022 Option Exercise$1.7412,72022,13312,720Aug 12, 2022, 05:15 PM
Dake Benjamin TSee RemarksAug 11, 2022 Sale$23.931,34732,23279Aug 12, 2022, 05:15 PM
Dake Benjamin TSee RemarksAug 10, 2022 Sale$24.0912,720306,366780Aug 12, 2022, 05:15 PM
Dake Benjamin TSee RemarksAug 08, 2022 Option Exercise$1.746,94312,0816,943Aug 10, 2022, 05:15 PM
Dake Benjamin TSee RemarksAug 09, 2022 Option Exercise$1.748,70015,1388,700Aug 10, 2022, 05:15 PM
Dake Benjamin TSee RemarksAug 09, 2022 Sale$24.068,700209,3252,791Aug 10, 2022, 05:15 PM
Dake Benjamin TSee RemarksAug 08, 2022 Sale$24.626,943170,9622,954Aug 10, 2022, 05:15 PM
Cormorant Asset Management, LPFormer 10% OwnerJul 02, 2021 Buy$14.00500,0007,000,0002,030,691Jul 07, 2021, 04:45 PM
RA CAPITAL MANAGEMENT, L.P.DirectorJul 02, 2021 Buy$14.002,785,71438,999,9966,965,568Jul 06, 2021, 05:03 PM
Sofinnova Venture Partners X, L.P.10% OwnerJul 02, 2021 Buy$14.00357,1424,999,9883,758,686Jul 06, 2021, 04:28 PM
Katabi MahaDirectorJul 02, 2021 Buy$14.00357,1424,999,9883,758,686Jul 06, 2021, 04:27 PM
GRAYZEL DAVID S.DirectorJul 02, 2021 Buy$14.00535,7147,499,9963,103,879Jul 06, 2021, 04:27 PM
Atlas Venture Fund XII, L.P.10% OwnerJul 02, 2021 Buy$14.00535,7147,499,9963,103,879Jul 06, 2021, 04:26 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Dake Benjamin TSEE REMARKS09/07/202364
Dake Benjamin TSEE REMARKS09/06/20237,447
Dake Benjamin TSEE REMARKS09/07/2023450
Dake Benjamin TSEE REMARKS09/06/202359,187
Dake Benjamin TSEE REMARKS08/07/202321,041
Dake Benjamin TSEE REMARKS08/07/2023159,580
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER07/28/202311,723
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER07/28/202398,604
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER07/17/20239,677
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER07/17/202381,896
Dake Benjamin TSEE REMARKS07/06/202321,041
Dake Benjamin TSEE REMARKS07/06/2023171,284
NIVEN RALPHCHIEF SCIENTIFIC OFFICER07/05/20234,555
NIVEN RALPHCHIEF SCIENTIFIC OFFICER07/05/202338,915
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER07/03/202321,400
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER07/03/2023180,000
Dake Benjamin TSEE REMARKS06/06/202321,041
Dake Benjamin TSEE REMARKS06/06/2023167,416
NIVEN RALPHCHIEF SCIENTIFIC OFFICER06/05/20234,555
NIVEN RALPHCHIEF SCIENTIFIC OFFICER06/05/202336,576
Gillies HunterCHIEF MEDICAL OFFICER05/19/2023113
Gillies HunterCHIEF MEDICAL OFFICER05/19/20231,268
Gillies HunterCHIEF MEDICAL OFFICER05/17/20231,897
Gillies HunterCHIEF MEDICAL OFFICER05/17/202321,356
NIVEN RALPHCHIEF SCIENTIFIC OFFICER05/05/20234,555
NIVEN RALPHCHIEF SCIENTIFIC OFFICER05/05/202346,957
Dake Benjamin TSEE REMARKS05/08/202321,043
Dake Benjamin TSEE REMARKS05/08/2023224,160
Verwijs MarinusSENIOR VICE PRESIDENT, CMC05/03/202315,779
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER05/01/202332,100
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER05/01/2023309,088
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER05/02/202314,657
Gillies HunterCHIEF MEDICAL OFFICER04/21/20236,960
Gillies HunterCHIEF MEDICAL OFFICER04/21/202378,000
Dake Benjamin TSEE REMARKS04/06/202321,041
Dake Benjamin TSEE REMARKS04/06/2023186,829
NIVEN RALPHCHIEF SCIENTIFIC OFFICER04/05/20234,555
NIVEN RALPHCHIEF SCIENTIFIC OFFICER04/05/202340,942
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER04/03/202332,100
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER04/03/2023290,916
Dake Benjamin TSEE REMARKS03/06/202321,039
Dake Benjamin TSEE REMARKS03/06/2023243,954
NIVEN RALPHCHIEF SCIENTIFIC OFFICER03/06/20234,555
NIVEN RALPHCHIEF SCIENTIFIC OFFICER03/06/202353,440
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER03/01/202332,100
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER03/01/2023357,196
Dake Benjamin TSEE REMARKS02/06/202321,043
Dake Benjamin TSEE REMARKS02/06/2023252,881
NIVEN RALPHCHIEF SCIENTIFIC OFFICER02/06/20234,555
NIVEN RALPHCHIEF SCIENTIFIC OFFICER02/06/202354,612
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER02/01/202332,100
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER02/01/2023340,197
Dake Benjamin TSEE REMARKS01/06/202321,043
Dake Benjamin TSEE REMARKS01/06/2023267,203
NIVEN RALPHCHIEF SCIENTIFIC OFFICER01/05/20234,555
NIVEN RALPHCHIEF SCIENTIFIC OFFICER01/05/202359,405
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER01/03/202332,100
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER01/03/2023406,076
Dake Benjamin TSEE REMARKS12/12/20224,406
Dake Benjamin TSEE REMARKS12/12/202260,591
Eldridge George ASEE REMARKS12/09/20228,494
Eldridge George ASEE REMARKS12/12/202221,400
Eldridge George ASEE REMARKS12/09/202296,765
Eldridge George ASEE REMARKS12/12/2022300,428
Dake Benjamin TSEE REMARKS12/09/2022843
Dake Benjamin TSEE REMARKS12/08/202221,400
Dake Benjamin TSEE REMARKS12/09/20229,861
Dake Benjamin TSEE REMARKS12/08/2022226,449
Eldridge George ASEE REMARKS12/08/202225,704
Eldridge George ASEE REMARKS12/07/202224,903
Eldridge George ASEE REMARKS12/08/2022286,700
Eldridge George ASEE REMARKS12/07/2022230,083
Dake Benjamin TSEE REMARKS12/06/202284,635
Dake Benjamin TSEE REMARKS12/06/2022706,772
NIVEN RALPHCHIEF SCIENTIFIC OFFICER12/05/20224,555
NIVEN RALPHCHIEF SCIENTIFIC OFFICER12/05/202239,114
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER12/01/202232,100
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER12/01/2022270,000
Eldridge George ASEE REMARKS11/30/2022182
Eldridge George ASEE REMARKS11/30/20221,620
Eldridge George ASEE REMARKS11/23/20222,699
Eldridge George ASEE REMARKS11/23/202224,048
Eldridge George ASEE REMARKS11/22/2022372
Eldridge George ASEE REMARKS11/21/20224
Eldridge George ASEE REMARKS11/18/20221,843
Eldridge George ASEE REMARKS11/22/20223,308
Eldridge George ASEE REMARKS11/21/202238
Eldridge George ASEE REMARKS11/18/202216,805
Dake Benjamin TSEE REMARKS11/11/202213,264
Dake Benjamin TSEE REMARKS11/10/20223,852
Dake Benjamin TSEE REMARKS11/09/202229,960
Dake Benjamin TSEE REMARKS11/11/2022128,236
Dake Benjamin TSEE REMARKS11/10/202236,172
Dake Benjamin TSEE REMARKS11/09/2022250,677
Dake Benjamin TSEE REMARKS11/08/202217,918
Dake Benjamin TSEE REMARKS11/07/202236,757
Dake Benjamin TSEE REMARKS11/08/2022151,458
Dake Benjamin TSEE REMARKS11/07/2022322,894
NIVEN RALPHCHIEF SCIENTIFIC OFFICER11/07/20224,555
NIVEN RALPHCHIEF SCIENTIFIC OFFICER11/07/202243,194
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICER11/01/202220,241
Verwijs MarinusSENIOR VICE PRESIDENT, CMC11/02/202221,346
Dake Benjamin TSEE REMARKS10/18/202212,209
Dake Benjamin TSEE REMARKS10/18/2022120,287
Dake Benjamin TSEE REMARKS10/14/2022235
Dake Benjamin TSEE REMARKS10/17/20228,956
Dake Benjamin TSEE REMARKS10/17/202284,380
Dake Benjamin TSEE REMARKS10/14/20222,205
Dake Benjamin TSEE REMARKS10/10/202210,602
Dake Benjamin TSEE REMARKS10/10/202283,681
Dake Benjamin TSEE REMARKS10/06/202226,941
Dake Benjamin TSEE REMARKS10/07/202222,513
Dake Benjamin TSEE REMARKS10/07/2022168,460
Dake Benjamin TSEE REMARKS10/06/2022206,344
NIVEN RALPHCHIEF SCIENTIFIC OFFICER10/05/20224,555
NIVEN RALPHCHIEF SCIENTIFIC OFFICER10/05/202235,447
Dake Benjamin TSEE REMARKS09/12/202216,093
Dake Benjamin TSEE REMARKS09/12/2022130,307
Dake Benjamin TSee Remarks09/08/20225,429
Dake Benjamin TSee Remarks09/09/20229,998
Dake Benjamin TSee Remarks09/08/202256,782
Dake Benjamin TSee Remarks09/09/202282,803
Dake Benjamin TSee Remarks09/07/202214,303
Dake Benjamin TSee Remarks09/06/202215,949
Dake Benjamin TSee Remarks09/07/202267,477
Dake Benjamin TSee Remarks09/06/2022169,876
NIVEN RALPHChief Scientific Officer09/06/20224,555
NIVEN RALPHChief Scientific Officer09/06/202242,750
NIVEN RALPHChief Scientific Officer08/18/20224,555
NIVEN RALPHChief Scientific Officer08/18/202247,657
Dake Benjamin TSee Remarks08/16/202236,540
Dake Benjamin TSee Remarks08/16/2022482,932
Dake Benjamin TSee Remarks08/11/20222,344
Dake Benjamin TSee Remarks08/10/202222,133
Dake Benjamin TSee Remarks08/11/202232,232
Dake Benjamin TSee Remarks08/10/2022306,366
Dake Benjamin TSee Remarks08/08/202212,081
Dake Benjamin TSee Remarks08/09/202215,138
Dake Benjamin TSee Remarks08/09/2022209,325
Dake Benjamin TSee Remarks08/08/2022170,962
Cormorant Asset Management, LPFormer 10% Owner07/02/20217,000,000
RA CAPITAL MANAGEMENT, L.P.Director07/02/202138,999,996
Sofinnova Venture Partners X, L.P.10% Owner07/02/20214,999,988
Katabi MahaDirector07/02/20214,999,988
GRAYZEL DAVID S.Director07/02/20217,499,996
Atlas Venture Fund XII, L.P.10% Owner07/02/20217,499,996
Load More Insider Transactions
FUNDS WITH A POSITION IN AEROVATE THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RA CAPITAL MANAGEMENT, L.P.8,263,9822.68%No changeOther
BAKER BROS. ADVISORS LP1,963,4790.19%No changeOther
DRIEHAUS CAPITAL MANAGEMENT LLC1,194,0910.26%NewGrowth
ORBIMED ADVISORS LLC756,9300.24%No changeOther
BLACKROCK INC.622,6470.00029%3.77%Other
GEODE CAPITAL MANAGEMENT, LLC203,0580.00041%8.3%Other
ALPS ADVISORS INC18,3200.00273%13.03%Other
CHANGE IN SHARES OUTSTANDING FOR AEROVATE THERAPEUTICS INC
STOCK BUYBACKS FOR AEROVATE THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2023
03/31/2023
1.57%
1Q
06/30/2023
12/31/2022
2.25%
2Q
06/30/2023
09/30/2022
2.91%
3Q
06/30/2023
06/30/2022
3.10%
4Q
06/30/2023
03/31/2022
3.10%
5Q
06/30/2023
09/30/2021
5.37%
7Q
Load More

Period of Report: 06/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2023
1.57%
1Q
12/31/2022
2.25%
2Q
09/30/2022
2.91%
3Q
06/30/2022
3.10%
4Q
03/31/2022
3.10%
5Q
09/30/2021
5.37%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AEROVATE THERAPEUTICS INC
LOADING...